Author

E. R. Gerstner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:imaging· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. E. Kim· 2 shared M. Martinez-Lage· 2 shared R. J. Sullivan· 2 shared A. Dahal· 1 shared A. Eichler· 1 shared A. Giobbie-Hurder· 1 shared A. Jain· 1 shared A. Kaplan· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. E. Kim

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy

A. E. Kim, K. W. Lou, A. Giobbie-Hurder, K. Chang, M. Gidwani, K. Hoebel, J. Patel, M. Cleveland, P. Singh, C. Bridge, S. R. Ahmed, B. Bearce, W. Liu, E. Fuster-Garcia, E. Lee, , E. R. Gerstner

This study links structural and functional vascular dysfunction in brain metastases to pembrolizumab resistance by analyzing perfusion MRI data from 44 patients.

bioRxiv · Aug 25, 2023 · PreprintCancer Biology

Microenvironmental correlates of immune checkpoint inhibitor response in human melanoma brain metastases revealed by T cell receptor and single-cell RNA sequencing

C. A. Alvarez-Breckenridge, S. C. Markson, J. H. Stocking, N. Nayyar, M. Lastrapes, M. R. Strickland, A. E. Kim, M. de Sauvage, A. Dahal, J. M. Larson, J. L. Mora, A. W. Navia, B. M. Kuter, C. M. Gill, M. S. Bertalan, , Bra

bioRxiv · Aug 25, 2021Cancer Biology

Altered structural hub connectivity and its clinical relevance in glioma

L. Douw, J. J. Miller, M. D. Steenwijk, S. M. Stufflebeam, E. R. Gerstner

This study examines structural hub connectivity in glioma patients and finds altered connectivity in the hemisphere opposite the tumor, linked to performance status and molecular subtypes.

bioRxiv · Apr 16, 2019 · PreprintCancer Biology